Fujifilm Diosynth Biotechnologies appoints Christine Vannais COO of North Carolina site
Fujifilm Diosynth Biotechnologies has appointed Christine Vannais as chief operating officer at its North Carolina site, the biologics focused CDMO said Monday.
Vannais joined FDB in 2012 and has led the North Carolina manufacturing operations team since 2014. In this role, she was responsible for the site’s 24/7 manufacturing operations, including cGMP production in both microbial and mammalian systems.
Incoming FDB president & CEO Martin Meeson said Vannais “brings a wealth of experience and demonstrated leadership. Christine will be a key contributor in our continued growth, aligned with our mission to be Partners for Life, advancing tomorrow’s medicines.”
Vannais has over twenty years of experience working in several industries including contract biopharmaceutical development and manufacturing, USDA biological vaccine manufacturing and research, FDA and EU small molecule manufacturing, primary and secondary packaging operations, API potent compound manufacturing, Department of Defense sites, among others.
Both Vannais and Meeson will take up their new roles effective April 1.
FDB has sites in Teesside, UK, Research Triangle Park, North Carolina, College Station, Texas and Hillerod, Denmark.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance